Category: Featured Story

Mesothelioma is one of the most aggressive and challenging cancers to treat. The infected cells fight off standard cancer treatments and continue to grow and divide leaving doctors and patients frustrated at the inability to stop the rogue cells. Now, researchers say that they are working on building a Pac-Man-like artificial cell that can gobble …

This article is a correction from the original that inadvertently stated that defactinib was approved by the U.S. FDA. It should have said paclitaxel was approved by the FDA. In November, MesotheliomaHelp announced the start of the global clinical trial named COMMAND (Control Of Mesothelioma with MAiNtenance Defactinib), to assess the overall survival and progression …

Jon Matthews is a betting man. Turns out, he’s also a lucky one. After lung surgery in June 2006, doctors told Matthews he had only a few months left to live. Instead of giving up, in early 2007 he took his odds to his bookie and asked to place a $300 bet that he would …